A prospective, randomized trial with quadruple versus dual tacrolimus-based induction after liver transplantation

被引:6
|
作者
Langrehr, JM [1 ]
Klupp, J [1 ]
Pfitzmann, R [1 ]
Neumann, U [1 ]
Lohmann, R [1 ]
Jonas, S [1 ]
Neuhaus, R [1 ]
Steinmüller, T [1 ]
Neuhaus, P [1 ]
机构
[1] Humboldt Univ, Dept Surg, D-13353 Berlin, Germany
关键词
D O I
10.1016/S0041-1345(00)02579-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
下载
收藏
页码:1520 / 1520
页数:1
相关论文
共 50 条
  • [21] Prospective and Randomized Trial Comparing Tacrolimus Versus Sirolimus after Simultaneous Pancreas-Kidney Transplantation
    Cantarovich, D.
    Papuchon, E.
    Blancho, G.
    Dantal, J.
    Giral, M.
    Branchereau, J.
    Karam, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 174 - 174
  • [22] Low rejection rates with tacrolimus-based dual and triple regimens following liver transplantation.
    Boillot, O
    Baulieux, J
    Wolf, P
    Messner, M
    Cherqui, D
    Gugenheim, J
    Pageaux, G
    Belghiti, J
    Calmus, Y
    Treut, YL
    Neau-Cransac, M
    Samuel, D
    HEPATOLOGY, 1999, 30 (04) : 310A - 310A
  • [23] Pharmacoeconomic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation
    Rabkin, JM
    Corless, CL
    Rosen, HR
    Olyaei, AJ
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1532 - 1534
  • [24] A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation
    Hachem, Ramsey R.
    Yusen, Roger D.
    Chakinala, Murali M.
    Meyers, Bryan F.
    Lynch, John P.
    Aloush, Aviva A.
    Patterson, G. Alexander
    Trulock, Elbert P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (10): : 1012 - 1018
  • [25] A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: A single center report
    Jain, A
    Kashyap, R
    Dodson, F
    Kramer, D
    Hamad, I
    Khan, A
    Eghestad, B
    Starzl, TE
    Fung, JJ
    TRANSPLANTATION, 2001, 72 (06) : 1091 - 1097
  • [26] Oral vs intravenous tacrolimus-based induction therapy in renal transplantation
    Tojimbara, T
    Kimikawa, M
    Nakajima, I
    Sato, S
    Nakamura, M
    Ishida, H
    Tanabe, K
    Koyama, I
    Utsumi, K
    Sannomiya, A
    Tsuji, K
    Fuchinoue, S
    Agishi, T
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (07) : 2763 - 2764
  • [27] Overview of tacrolimus-based immunosuppression after heart or lung transplantation
    Reichenspurner, H
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : 119 - 130
  • [28] Long Term NODAT Outcomes from a Prospective Randomized Trial of Belatacept-Based versus Tacrolimus-Based Early Corticosteroid Withdrawal Regimens
    Yanqui, E.
    Woodle, E.
    Govil, A.
    Kremer, J.
    Cuffy, M.
    Anand, M.
    Alloway, R.
    Shields, A. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S561 - S562
  • [29] Artificial Intelligence Based Dosing of Tacrolimus in Liver Transplantation: Prospective, Randomized Phase 2 Trial.
    Zarrinpar, A.
    Ho, C.
    Warren, C.
    Khong, J.
    Lee, M.
    Duarte, S.
    Andreoni, K.
    Johnson, M.
    Battula, N.
    McKimmy, D.
    Beduschi, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 567 - 567
  • [30] Tacrolimus-based immunosuppression is efficacious and safe with both dual and triple drug regimens following liver transplantation
    Salizzoni, M
    Battista, AOSG
    HEPATOLOGY, 1999, 30 (04) : 171A - 171A